When chronic nerve pain has not responded to medication, injections, or surgery, a small implanted device may quiet the pain signals before they reach your brain. Explore how it works, how the different waveforms feel, and how you would test it with a trial before committing to an implant.
A way to manage chronic pain by changing the pain signal itself, rather than repairing the structure that started it. A thin lead sits in the epidural space and delivers gentle electrical pulses to the back of the spinal cord, interrupting pain signals before they reach the brain.
A 5 to 7 day outpatient trial with temporary leads lets you test real pain relief before committing to a permanent implant.
The device can be turned off, reprogrammed, or removed at any time. There are no permanent structural changes to your spine.
Multiple waveforms — tonic, burst, and HF10 — can be tuned to your pain pattern and to what feels best for you.
Pain signals travel up the spinal cord to the brain. A spinal cord stimulator sits in the epidural space and interrupts those signals before they arrive. Change the stimulation mode and watch what happens.
Select a stimulation mode below. Watch the red pain pulses travel up the cord, see how many still reach the brain, and read what the mode would feel like. When a mode is on, use the sliders to adjust frequency and amplitude.
This simulation is a simplified, educational illustration of how stimulation waveforms interact with pain signaling. It is not a measurement of your own pain or a prediction of your result.
SCS works best for nerve-related (neuropathic) pain in the arms or legs that has not responded to other care. The trial is itself the best test of candidacy.
The great advantage of SCS is that you get to try it before you commit. A short trial predicts whether a permanent implant will help.
A detailed pain history, exam, psychological evaluation, and review of your imaging to confirm SCS is a sensible option.
An outpatient procedure. Temporary leads are placed through a needle under live X-ray (fluoroscopy), typically in about 30 minutes.
You go home with an external stimulator and test real relief during your normal activities, keeping track of how you feel.
If the trial gives meaningful relief (generally at least 50%) and better function, the permanent leads and battery (IPG) are placed as an outpatient.
Because you trial the therapy first, SCS has an unusually honest built-in filter: most people who proceed to an implant do so because they already felt it work.
SCS is generally low-risk, but no procedure is risk-free. The most common issues relate to the hardware: a lead can shift out of position (lead migration), which may change or reduce coverage and sometimes needs adjustment; the battery eventually needs recharging and, after years, replacement. Other risks include infection, bleeding, pain at the battery pocket, and, uncommonly, a small tear in the lining around the nerves (dural puncture) causing a headache. Rarely, the therapy simply does not provide lasting relief, which is exactly what the trial is designed to reveal before an implant.
SCS also affects future imaging and devices: your team will counsel you about MRI compatibility (many modern systems are MRI-conditional) and interactions with other implanted devices. Because the trial is reversible and low-commitment, it lets you weigh real benefit against these trade-offs before deciding.
This educational resource was developed by Brown Neurosurgery to help patients and families understand spinal cord stimulation for chronic pain. Our neuromodulation team works alongside pain management, physiatry, and psychology to make sure SCS is offered to the right patients, and to support you through the trial, implant, and long-term programming.
Norman Prince Spine Institute — they evaluate your candidacy and place and manage the temporary trial.
Neurosurgery — they perform the permanent implant once the trial confirms meaningful relief.
For full faculty profiles, visit the Brown Neurosurgery website.